Startups 2024
Emerging Startup
PromentalHealth
Innovation & Business Idea
A blood test based on microRNA signature to allow the early, non-invasive, inexpensive diagnosis of AD and will help to monitor the status of the disease. A further tool will be developed to give a prognosis for individuals who don’t have symptoms. In both cases a software developed with the help of an ML method will be used for the evaluation of the blood values.
Contact
Dr Nora Gedeon
nora.gedeon@mailbox.org
tel. 00436645337014
